These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 17367706)

  • 1. Impact of impaired fasting glucose and other metabolic factors on cognitive function in elderly people.
    Di Bonito P; Di Fraia L; Di Gennaro L; Vitale A; Lapenta M; Scala A; Iardino MR; Cusati B; Attino L; Capaldo B
    Nutr Metab Cardiovasc Dis; 2007 Mar; 17(3):203-8. PubMed ID: 17367706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in cognitive impairment: the InCHIANTI study.
    Geroldi C; Frisoni GB; Paolisso G; Bandinelli S; Lamponi M; Abbatecola AM; Zanetti O; Guralnik JM; Ferrucci L
    Arch Neurol; 2005 Jul; 62(7):1067-72. PubMed ID: 16009759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study.
    Meigs JB; Larson MG; Fox CS; Keaney JF; Vasan RS; Benjamin EJ
    Diabetes Care; 2007 Oct; 30(10):2529-35. PubMed ID: 17586736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
    Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
    Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study.
    Stein PK; Barzilay JI; Domitrovich PP; Chaves PM; Gottdiener JS; Heckbert SR; Kronmal RA
    Diabet Med; 2007 Aug; 24(8):855-63. PubMed ID: 17403115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of glucose tolerance status in patients with asthma bronchiale.
    Gulcan E; Bulut I; Toker A; Gulcan A
    J Asthma; 2009 Mar; 46(2):207-9. PubMed ID: 19253132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
    Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
    Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database.
    Sesti G; Andreozzi F; Bonadonna RC; De Mattia G; Leonetti F; Luzi L; Marini MA; Natali A; Vettor R; Bonora E;
    Diabetes Metab Res Rev; 2008 Feb; 24(2):130-6. PubMed ID: 17922529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.
    Hanley AJ; Wagenknecht LE; Festa A; D'Agostino RB; Haffner SM
    Diabetes Care; 2007 Jul; 30(7):1819-27. PubMed ID: 17429060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
    Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
    Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
    Harati H; Hadaegh F; Tohidi M; Azizi F
    Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes.
    Mainous AG; Diaz VA; King DE; Everett CJ; Player MS
    J Am Board Fam Med; 2008; 21(6):497-503. PubMed ID: 18988716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of beta-cell function to compensate lack of insulin action in hyperuricemic subjects.
    Simental-Mendía LE; Rodríguez-Morán M; Guerrero-Romero F
    Diabetes Metab Res Rev; 2009 Sep; 25(6):535-41. PubMed ID: 19557736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal vascular caliber and the long-term risk of diabetes and impaired fasting glucose: the Blue Mountains Eye Study.
    Kifley A; Wang JJ; Cugati S; Wong TY; Mitchell P
    Microcirculation; 2008 Jul; 15(5):373-7. PubMed ID: 18574740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.